The science
The evidence for this serum divides cleanly into a base that is well understood and a headline that is not. The base first. Squalane, second in the list, is a hydrogenated, skin-identical lipid with a long record of emollience and tolerability; saccharide isomerate is a plant-sugar humectant that binds to keratin's amino groups and resists rinsing, giving multi-hour hydration; glycerin and propanediol are standard humectants. Together they explain the immediate softening, the daily hydration and the smoother look of fine dehydration lines that a consumer panel would report — and they explain them without reference to the exosome.
The headline is Chlamydomonas reinhardtii extract, a source of plant-derived extracellular vesicles that Naturium markets as biomimetic exosomes. The current literature is candid about where that stands. A 2026 scoping review in Aesthetic Surgery Journal screened 2,394 articles and found eighteen evaluating topical exosomes for skin rejuvenation from human and plant sources; ten of those used a delivery modality such as microneedling alongside the exosomes, and the authors concluded that human studies remain scarce, that most evidence is extrapolated from preclinical models, and that commercial products carry minimal information on isolation, processing or shelf life — the review's own survey of twenty shopping-search products found exactly that ambiguity. A second 2026 scoping review in the Journal of Drugs in Dermatology identified seventeen human studies across dermatology, predominantly using mesenchymal-stem-cell-derived exosomes delivered by microneedling, laser or injection, and noted small samples, short follow-up, single-arm designs and potential conflicts of interest, with rare but serious adverse events after injection. Neither review identifies a trial of plant vesicles in a leave-on cosmetic on intact skin, which is the use here. Plant-derived nanovesicles have promising in vitro data on uptake and anti-inflammatory signalling, but whether they cross an unbroken stratum corneum in meaningful numbers is unestablished.
Hexapeptide-9, listed last, is a synthetic peptide with supplier data on collagen and laminin gene expression in fibroblasts and no independent clinical trials; at a trace level in a 26-ingredient list it cannot be expected to contribute. The brand's 91 and 94 percent figures are self-reported perceptions from a panel of undisclosed size without a vehicle control and should be read as evidence that the hydrating base performs, not that the exosome does. The formula's safety profile, by contrast, is excellent: no fragrance, no sensitisers, no exfoliants, and a plant vesicle source that avoids the regulatory and immunological questions attached to human-cell-derived material.
References 2 ShowHide
- Clinical Evidence and Commercial Landscape of Topical Exosomes for Skin Rejuvenation: A Scoping Review — Aesthetic Surgery Journal (2026)
- Exosome-Based Therapies in Dermatology: A Scoping Review — Journal of Drugs in Dermatology (2026)